Purpose: To identify the causative gene for phenotypes associating autosomal recessive congenital cataract, mental retardation and congenital cataract, mental retardation and microcephaly in four unrelated Tunisian families. Methods: Four genes (EPHA2, GALK1, GCNT2, and CRYBB1) were selected based on their expression in human brain and their known or putative function. Linkage analysis were performed for the four genes in multiple affected and unaffected families' members and results were explored by the GeneMapper ID v3.2 software. Results: No linkage was identified for the four studied genes in the four families. Affected members of each family did not share common haplotypes in corresponding candidate regions containing selected gene. Conclusion: Although the four studied genes were reported responsible for autosomal recessive congenital cataract and highly expressed in the human brain, we report no linkage for EPHA2, GALK1, GCNT2, and CRYBB1 genes in four families with congenital cataract, mental retardation and congenital cataract, mental retardation and microcephaly.
Introduction
Congenital cataracts are one of the major causes of vision loss in children worldwide and are responsible for approximately one third of blindness in infants [1] . Congenital cataracts can occur in an isolated fashion or as one component of a syndrome affecting multiple tissues. Nonsyndromic congenital cataracts have an estimated frequency of 1 to 6 per 10,000 live births. They vary markedly in severity and morphology, affecting the nuclear, cortical, polar, or subcapsular parts of the lens or, in severe cases, the entire lens, with a variety of types of opacity. Approximately one third of congenital cataract cases are familial [2] .
Few autosomal recessive cataract loci have been mapped. To date, 13 loci residing on chromosomes 1p34.4-p32.2, 1q21.1, 3p22-24.2, 6p23-24, 9q13-22, 16q21-22, 19q13, 19q13.4, 20p12.1, 21q22.3, 22q11, 22q12.1 and 17q, have been mapped, with six of these also causing autosomal dominant cataracts [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] .
EPHA2 (Ephrin-receptor type-A2) belongs to the tyrosine kinase family of proteins and is an epithelial cell kinase that has been associated with autosomal dominant cataracts and recently it was implicated in ARCC in human [11] . EPHA2 is expressed in a variety of different regions during development. Expression has been observed in the hindbrain, specifically in rhombomere 4, during early embryogenesis [13] .
Galactokinase (GALK1) is involved in the first step of metabolism of galactose, the conversion of galactose to galactose-1-phosphate at the expense of ATP. In the absence of GALK1 the accumulating galactose is converted to galactitol by aldose reductase. Stambolian and colleagues first identified mutations in families with cataracts [14] . And recently GALK1 found to be mutated in Pakistani families with ARCC [12] .
Glucosaminyl (N-acetyl) Transferase 2 Gene (GCNT2) had been reported for ARCC in Arab families from Israel [4] . GCNT2 is highly expressed in fetal brain and kidney and adult brain but expressed ubiquitously in various adult tissues [15] .
Crystallin genes, which encode major structural proteins in the lens, are considered as obvious candidate genes of congenital cataracts owing to both their high levels of lenticular expression and their confirmed functions in maintaining lens transparency. Increasing evidence sug-gests the correlated relationship between mutations in the crystallin genes with the occurrence of congenital cataracts in humans [16] . βB1-crystallin gene (CRYBB1) mutations have been shown to underlie autosomal dominant congenital cataract [17] . To date, two reports had underlined CRYBB1 mutations associated with ARCC [10] .
This report describes the investigation of four positional and functional candidate genes of autosomal recessive congenital cataract (ARCC) for phenotypes associating ARCC, mental retardation (MR) and ARCC, MR, and microcephaly. The genes were chosen on the basis of lens and human brain expression.
Methods

Subjects and Sample Collection
We evaluated fifteen patients (6 parents, 9 patients) belonging to four unrelated Tunisian families (Figure 1 ) addressed to Congenital and Hereditary Disorders Department at Charles-Nicolle Hospital (Tunis, Tunisia).
All four families were of Tunisian origin and were enrolled in a genetic research program in the laboratory of Human Genetics, in the Faculty of Medicine (Tunis, Tunisia) because of four patients with ARCC and MR (two affected brothers belonging to family F2 and two patients of family F4) and five affected patients from families F1, F2, and F3 with ARCC, MR and microcephaly.
The nine patients (5 males, 4 females) were born from healthy and consanguineous parents. Pedigrees' patterns are concordant with autosomal recessive inheritance for the four families ( Figure 1 ). Their mean age was 23 years, ranging from 8 to 41 years. We noted that the father from family F1 was dead after a traumatic accident and the other from family F4 lived abroad. Cataracts were reportedly present since birth in all patients. None had glaucoma before or after the extraction of cataracts. The cataracts were of the posterior polar type and bilateral in all patients except of the affected children IV 12 belonging to family F3 and IV 13 from family F1. All patients had undergone cataract extraction early in life. Visual acuity was preserved in all patients except of the affected patients IV 11 from family F3 who showed decreased visual acuity and alteration of the pigment epithelium. We denoted the presence of retinal dystrophy and strabismus in patient IV 16 belonging to family F1. We underlined also the presence of strabismus (exotropia) in patient III 16 from family F4.
Significant physical disability became apparent for all patients by the age of 15 to 18 months when they failed to walk. They also had a significant delay in speech development. In fact, the nine affected patients were developmentally delayed with mild to moderate mental retardation with no dysmorphic features. Microcephaly, suspected since birth, was present in all of them except the two brothers IV 36 and IV 37 belonging to family F2 and the two patients from family F4. Additional features are shown in Table 1 .
Magnetic resonance imaging (MRI) of the brain was normal in all screened patients except for the presence of a small ischemic parietal lesion in patient IV 16 from family F1.
Biological investigations (karyotyping with R-banding) revealed normal karyotypes: 46, XX for females, 46, XY for males (600 bands resolution) and normal metabolic screening including Fehling reaction and thin layer chromatography of reducing sugars, plasmatic amino acid and urine organic acid chromatography for all patients.
Genomic DNA of affected and unaffected members (9 siblings, 6 parents) was extracted from peripheral blood leukocytes by the standard proteinase-K extraction consisting on: lysis of red blood cells by RBC (Red Blood Cells) Lysis Buffer (155 mM NH 4 Cl, 10 mM KHCO 3 , 0.5 EDTA, pH 7.5) and white blood cells by a WBC (White Blood Cells) Lysis Buffer (1 mM Na-EDTA, 5mM Tris HCl, pH 7.5), treatment of the lysate with a mixture of detergent composed of SDS (Sodium Dodecyl Sulfate or sacrosyl and proteinase K) in order to liberate the DNA and digest the associated proteins, precipitation of the DNA in the form of filaments by absolute ethanol and finally diluation of the DNA in T10E1 Buffer (Tris 10 mM, EDTA 0.1-1 mM), and stored in 10 ml Vacuum tube sterile containing 100 µl of 0.1 M EDTA.K3.
Patients and parents for minors gave informed consent. In this study, the researches carried out on human are in compliance with the Helsinki Declaration and ethics committee Charles Nicolle hospital, Tunis has given approval for this study.
Molecular and Genotyping Analysis
On the basis of the pedigree of the four studied families (Figure 1) , we suspected autosomal recessive inheritance for phenotypes associating congenital cataract, mental retardation and congenital cataract, mental retardation, and microcephaly.
All individuals were genotyped for eight microsatellite loci within a 10-cM region on 1p36.21-p35.2 previously reported as linked to EPHA2 (D1S2697-D1S1592-D1 S2644-D1S2864-D1S2787-D1S507-D1S434-D1S2667) [11, 13] , at six microsatellite loci on 17q22-q25.3 linked to GALK1 (D17S944-D17S1825-D17S1301-D17S1839-D17S785-D17S1847) [12] , at five microsatellite loci on 6p25-p23 reported as linked to GCNT2 (D6S1574-D6 S309-D6S470-D6S1034-D6S289) [4] , and at six microsatellite loci on 22q11.2-q12.1 previously reported as linked to CRYBB1 (D22S539-D22S686-D22S345-D22 S419-D22S1167-D22S1144) [10] .
Suitable microsatellite primers for polymerase chain reaction (PCR) amplification of each candidate region containing the candidate gene were designed using NCBI (http://www.ncbi.nlm.nih.gov/unists). PCR was performed by using 100 ng of DNA template, 20 pmol each of forward (FAM labelled) and reverse primers (Biomatik, Canada), 1.5 units of Taq DNA polymerase (Promega, Madison, WI) and 1.25 mM dNTPs (Promega, Madison, WI) in a total volume of 25 μl. PCR consisted on 30 cycles and was carried out in an automated thermal cycle GeneAmp PCR System 9700 (Applied Biosystems, California) under the following conditions: initial denaturation at 96˚C for 5 min and denaturation at 96˚C for 30 s, annealing at 52˚C -60˚C for 30 s, and elongation at 72˚C for 30 s followed by one cycle of final extension at 72˚C for 7 min. Genotyping was performed on a genetic analyser (PRISM 3130; ABI) with accompanying software (GeneScan; ABI, Foster City, CA).
Linkage Analysis
Two-point LOD scores were calculated using the MLINK program of the LINKAGE package (ver. 4.1P; http:www.hgmp.mrc.ac.uk; provided in the public domain by the Human Genome Mapping Project Resources Centre, Cambridge, UK), and multipoint and haplotype analyses were performed with GeneMapper ID v3.2 software.
Results
Segregation analysis using the polymorphic markers on chromosome 1 for EPHA2, on chromosome 17 for GALK1, on chromosome 6 for GCNT2 and on chromosome 22 for CRYBB1 within minimum 10-cM region allowed us to exclude implication in studied phenotypes (congenital cataract, mental retardation and congenital cataract, mental retardation, and microcephaly) of all regions analyzed seeing that the affected members and their parents did not share a common haplotype.
There is no linkage of anyone of the four genes (EPHA2, GALK1, GCNT2, and CRYBB1) to the association between ARCC, MR and ARCC, MR, and microcephaly in the four studied families (F1, F2, F3, and F4 ).
Discussion
Congenital cataracts are common major abnormalities of the eye, which frequently cause blindness in infants. It may occur as an isolated anomaly, as part of generalized ocular development defects, or as a component of a multisystem disorder [18] . In fact, association of cataract with congenital anomalies, mental retardation and microcephaly is reported in several cases with chromosomal anomalies and syndromes from genic origins [19] [20] [21] .
Until today no candidate gene has been reported responsible for phenotypes associating ARCC, MR and ARCC, MR, and microcephaly, so we tried to investigate genes already described in ARCC and highly expressed in the human brain particularly during embryogenesis (EPHA2, GALK1, GCNT2, and CRYBB1).
EPHA2 belongs to the tyrosine kinase family, and the protein EphA2 is an epithelial cell kinase that interacts with membrane-bound ephrin ligands, which play an important role in morphogenesis and in numerous developmental processes [22] . For the first time, it was reported responsible for autosomal dominant cataracts (ADCC) and recently it was implicated in age-related cortical cataracts in humans and mice [14, 23] . In 2010, Kaul et al. reported the first missense mutation leading to an ARCC in a consanguineous Pakistani family [11] . EPHA2 is transcribed abundantly in tissues or cells of epithelial origin, although the expression is not limited to epithelial cells. EPHA2 is expressed in a variety of different regions during development [13, 14] . Expression has been observed in the distal region of the primitive streak and in the hindbrain, specifically in rhombomere 4, during early embryogenesis. Later in development, expression is detected in the branchial arches, neurogenic facial crest VII-VIII and IX-X, and in the limb bud mesenchyme. In the central nervous system, EPHA2 is widely transcribed in the ventricular zone cells in midgestation [14] .
GALK1 is involved in the first step of metabolism of galactose, the conversion of galactose to galactose-1-phosphate at the expense of ATP. In the absence of GALK1 the accumulating galactose is converted to galactitol by aldose reductase. Stambolian and colleagues first identified mutations in GALK1 in families with cataracts [12] . Recently, Yasmeen and coworkers reported a missense mutation and a single base pair deletion leading to ARCC in a consanguineous Pakistani family. GALK1 found to be highly expressed in many human organs from foetuses to adults; brain, heart, kidney, liver, lung, muscle and spleen [24] .
For GCNT2 three splicing variants GCNT2A, -B, and -C, which differ at exon 1 but have identical exon 2 and 3 coding regions, are expressed differentially in specific tissues. Mutation events that occur in the specific exon 1 region of the GCNT2 gene may lead to a defect in one form of the GCNT2 enzyme and I phenotype in certain cell types, whereas those that occur in the common exon 2 to 3 region result in i phenotype as well as congenital cataract, because of the elimination of activity of all three forms of the GCNT2 enzymes [25] . Pras and colleagues reported four distantly related Arab families from Isreal with a nonsense mutation in the GCNT2 gene isoforms associated to ARCC [4] .
GCNT2 isoforms are abundantly expressed in various none rythroid tissues. In fetal tissues, GCNT2 was substantially expressed in brain and moderately expressed in kidney and lung but was almost undetectable in liver. In adult tissue, GCNT2 was strongest in prostate, moderate in small intestine and colon, and barely detected in heart, brain, kidney, and pancreas. In adult brain, GCNT2 is much more prominent in cerebellum than the other parts of brain [15] .
Crystallins (α-crystallin family and the β/γ-crystallin superfamily) are highly stable major constituents of the vertebrate eye lens and comprise approximately 90% of the water-soluble lens proteins. They have a particular spatial arrangement critical to the transparency of the lens and are hence good candidate genes for congenital cataract disease [26] . To our knowledge, there are only six previous reports of CRYBB1 mutations in patients with congenital cataract and only two of these in patients with autosomal recessive cataract [10, 17] . β-crystallins are expressed from early developmental stages in the eye lens, their expression continues and rises after birth so that the highest concentrations are usually found in the lens cortex.
Taking these results further, we tried to investigate the existence of a possible association between one or more of these genes (EPHA2, GALK1, GCNT2, and CRYBB1) and studied phenotypes in the four Tunisian families (ARCC, MR and ARCC, MR, and microcephaly). No linkage was detected in the four genotyped candidate regions containing each gene for the four studied families. These findings did not exclude the role of EPHA2, GALK1, GCNT2, and CRYBB1 genes in both ocular and central nervous system but it underlined the fact that none of these genes could be responsible for the association between congenital cataract, mental retardation and congenital cataract, mental retardation, and microcephaly (suspected since birth in all examined patients) in these families.
In conclusion, a genome wide scan must be performed for these four families in order to identify candidate regions and candidate gene(s) leading to the unreported associations between ARCC, MR and ARCC, MR, microcephaly.
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